Recent posts

TypePostAuthorRepliesLast updated
Blog entryWorkshop: Patents, the Public Interest and Two New Medical Technologies: CRISPR and CAR T Kim Treanor04 hours 17 min ago
Book pageKEI Mission James Love01 day 14 hours ago
PageAbout KEI James Love01 day 14 hours ago
Blog entryPresidential Advisory Council on Combating Antibiotic-Resistant Bacteria unanimously endorses delinkage James Love03 days 3 hours ago
Blog entryKEI asks HHS to use Bayh-Dole rights in Zinbryta patent (drug for multiple sclerosis) KEI Staff05 days 9 hours ago
Page2017: Nanobernetics license James Love01 week 1 day ago
Blog entrySEARO RC70: Statement of Knowledge Ecology International on Access to Medicines thiru01 week 2 days ago
PageNIH CRADAs, 2010 to 2016 James Love02 weeks 2 hours ago
Page2017: Nanobernetics proposed exclusive license for NIH patents on Apparatus for Microarray Binding Sensors James Love02 weeks 23 hours ago
Blog entryKymriah, the Novartis $475,000 CAR T treatment, received 50 percent Orphan Drug tax credit on trials James Love02 weeks 6 days ago
Blog entryUS Federal rights in patents on Probuphine, to treat opioid addiction Kim Treanor03 weeks 2 hours ago
ImageProbuphine-implant Kim Treanor03 weeks 6 hours ago
Blog entryWHO draft concept note on strategic priorities for 2019-2023 charts a new vision for the organization thiru03 weeks 15 hours ago
Page2016: Dedalus Pharma, LLC, KEI comments on NIH proposal for exclusive licenses on CARs to treat cancer Diane Singhroy03 weeks 1 day ago
Page2016: Chimeron Bio: KEI comments on NIH proposal for exclusive license for patents on cancer treatments Diane Singhroy03 weeks 1 day ago
Blog entry2015: Virotas Biopharmaceuticals. KEI and Public Citizen ask NIH for safeguards in license for HCV patents James Love03 weeks 1 day ago
Blog entry2016: AltraTech, KEI comments on NIH proposal for exclusive licenses for vitro diagnostics patents KEI Staff03 weeks 1 day ago
Blog entry2016: Kite Pharma, KEI Comments on NIH Proposed Exclusive License for Cancer Treatment Claire Cassedy03 weeks 1 day ago
Page2016: MeiraGTx, NIH license of patents on AAV­Mediated Aquaporin Gene Transfer To Treat Sjögren's Syndrome James Love03 weeks 1 day ago
StorySources for Researching Drug Prices Anne Mira Guha03 weeks 1 day ago
Blog entryKEI statement regarding Gilead’s Acquisition of Kite Pharma James Love03 weeks 2 days ago
Book pageJames Love, Director James Love03 weeks 2 days ago
Blog entry2017: miRecule/NIH license on MicroRNA Therapeutics for Treating Squamous Cell Carcinomas James Love03 weeks 2 days ago
Page2017: Salubris Biotherapuetics: Bispecific, Biparatopic Antibody-Drug Conjugate for Human Liver Cancers James Love03 weeks 5 days ago
PageKim Treanor, Communications and Development Claire Cassedy04 weeks 2 days ago